Growing Too Fast: S...
Health Care: Drugs
Emergent BioSolutions Incorporated (EBS: NYSE)
$17.72 -0.13 | -0.73%
02/09/12 - 04:03 PM ET
111.31K / 174.30K
Vol / Avg. Vol:17.85 / 17.85
Open / Prev. Close:17.50 - 17.85
Today's Range:14.90 - 26.41
52 Wk Range:6.00%
Performance YTD:TheStreet Rating:
Portfolios with EBS
- Portfolio NameUser Type
- Contributor9 Health Care Stocks With 1...
- UserRMF watchlist
- Userinvst2011
- UserDividend & Stable
- UserMSSB Trading
- UserPART 2 JPMorgan 28th Annual...
- Userdurfee
- UserBEN COLLEGE
- UserMAC88831
- UserSUPRATRADE EX-1006090013 DE...
Latest EBS Headlines from TheStreet
- Emergent BioSolutions' President Presents At The 30th Annual J.P. Morgan Healthcare Conference (Transcript) 01.10.12 | 07:01 pm
- Emergent BioSolutions Incorporated Stock Downgraded (EBS) 11.08.11 | 05:11 am
- Emergent BioSolutions' CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.03.11 | 10:11 pm
- Emergent BioSolutions' CEO Discusses Q2 2011 Results - Earnings Call Transcript 08.04.11 | 10:08 pm
- Emergent BioSolutions Rises On Unusually High Volume (EBS) 05.26.11 | 11:05 am
- Emergent BioSolutions CEO Discusses Q1 2011 Results - Earnings Call Transcript 05.05.11 | 10:05 pm
- 9 Health Care Stocks With 100% Buy Ratings 05.05.11 | 04:05 pm
- Emergent BioSolutions Reaches New 52-Week High (EBS) 04.13.11 | 11:04 am
- Emergent BioSolutions CEO Discusses Q4 2010 Results - Earnings Call Transcript 03.10.11 | 09:03 pm
- Emergent BioSolutions CEO Discusses Q3 2010 Results  Earnings Call Transcript 11.05.10 | 01:11 am
Press Releases for EBS
- Emergent BioSolutions To Release Fourth Quarter And Full Year 2011 Financial Results And Conduct A Conference Call On March 8, 2012 - Business Wire 01.30.12 | 07:01 am
- Emergent BioSolutions Provides Preliminary 2011 Financial Results And Provides Guidance For 2012 - Business Wire 01.09.12 | 07:01 am
- Emergent Announces Plans For TRU-016 Program Following Termination Of Collaboration With Abbott - Business Wire 12.28.11 | 07:12 am
- Emergent Initiates Phase 2 Study Of TRU-016 In Combination With Bendamustine In Patients With Relapsed Chronic Lymphocytic Leukemia - Business Wire 12.28.11 | 07:12 am
- Emergent BioSolutions Announces Fuad El-Hibri To Retire As CEO, Remain As Executive Chairman Of The Board Of Directors Focused On Corporate Strategy And M&A Opportunities - Business Wire 12.21.11 | 02:12 pm
- Emergent BioSolutions To Participate In January 2012 Investor Conferences - Business Wire 12.12.11 | 07:12 am
- Emergent BioSolutions Announces Acceptance Of Four TRU-016 Abstracts For Presentation At 2011 American Society Of Hematology Annual Meeting - Business Wire 12.05.11 | 07:12 am
- Emergent BioSolutions Receives Orphan Drug Designation For Its TRU-016 Protein Therapeutic For The Treatment Of Chronic Lymphocytic Leukemia - Business Wire 12.01.11 | 07:12 am
- Emergent BioSolutions Initiates Pivotal Clinical Trial Evaluating A Three-Dose BioThrax Regimen For Post-Exposure Prophylaxis - Business Wire 11.17.11 | 06:11 am
- Emergent BioSolutions Reports Financial Results For Third Quarter And First Nine Months Of 2011 - Business Wire 11.03.11 | 04:11 pm
Partner Headlines for EBS
- Company News for October 7, 2011 - Corporate Summary - Zacks 10.07.11 | 10:10 am
- Progress Software Reports Positive Quarter, Poor Guidance - Benzinga 09.27.11 | 04:09 pm
- Fisher Investments' Healthcare Picks: Large Caps Trumping Small Caps - Seeking Alpha 07.14.11 | 09:07 am
- Progress Software Roll Over in the After-Hours - Benzinga 06.28.11 | 04:06 pm
- 3 Low Beta Pharma Growth Stocks for Uncertain Times - Seeking Alpha 05.22.11 | 08:05 am
- Top 15 Most Undervalued Biotech Stocks By Analyst Target Price - Seeking Alpha 04.08.11 | 03:04 pm
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 01.13.11 | 09:01 am
- UPDATE 1-Drugmaker Emergent raises 2010 view; sees strong 2011 - Reuters 01.10.11 | 08:01 am
- US announces three biodefense vaccine contracts - Reuters 10.07.10 | 11:10 am
- Biotech's Slow Week Gets Stirred by a Few Smaller Deals - Seeking Alpha 08.15.10 | 04:08 am
